Treatment of infections caused by rapidly growing mycobacteria in the era of the newer macrolides.
Wallace
R J
RJ
Department of Microbiology, University of Texas Health Center, Tyler 75710, USA.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D007769:Lactams; D018942:Macrolides; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy* / Q000601:surgery; D013449:Sulfonamides / Q000627:therapeutic use; D013754:Tetracyclines
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D007769:Lactams; D018942:Macrolides; D013449:Sulfonamides; D013754:Tetracyclines